NCT04842201View on ClinicalTrials.gov

Single Ascending Dose Study of CM326 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 13, 2021

Primary Completion Date

September 28, 2021

Study Completion Date

September 28, 2021

Conditions
Asthma
Interventions
DRUG

CM326

subcutaneous injection

DRUG

Placebo

subcutaneous injection

Trial Locations (1)

Unknown

PKUCare Luzhong Hospital, Zibo

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT04842201 - Single Ascending Dose Study of CM326 in Healthy Volunteers | Biotech Hunter | Biotech Hunter